Reikes Peter N 4
4 · IONIS PHARMACEUTICALS INC · Filed Jul 19, 2021
Insider Transaction Report
Form 4
Reikes Peter N
Director
Transactions
- Exercise/Conversion
Common Stock
2021-07-15+5,333→ 10,667 total - Exercise/Conversion
Common Stock
2021-07-15+1,778→ 12,445 total - Exercise/Conversion
Restricted Stock Unit
2021-07-15−5,333→ 14,219 totalExercise: $0.00→ Common Stock (5,333 underlying) - Exercise/Conversion
Restricted Stock Unit
2021-07-15−1,778→ 12,441 totalExercise: $0.00→ Common Stock (1,778 underlying)
Footnotes (4)
- [F1]Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F3]Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
- [F4]Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.